Studies of thrombectomy devices made by Medtronic's Covidien, Stryker and Penumbra show that they dramatically improve the likelihood that patients will recover from stroke.
(Reuters) - Grabbing and removing a clot blocking blood flow to the brain via thrombectomy, rather than just administering clot-busting drugs, dramatically improves the likelihood that patients will recover from a stroke, according to 2 highly-anticipated studies released today.
American Stroke Assn., Covidien, International Stroke Conference, Medtronic, Penumbra Inc., Stryker, American Heart Assn.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/16US4aI
Cap comentari:
Publica un comentari a l'entrada